Detalus Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,350
| Closed | -$453K | – | 140 |
|
|
2022
Q3 | $453K | Sell |
7,350
-225
| -3% | -$13.9K | 0.27% | 73 |
|
|
2022
Q2 | $468K | Buy |
7,575
+100
| +1% | +$6.18K | 0.28% | 66 |
|
|
2022
Q1 | $444K | Buy |
7,475
+1,175
| +19% | +$69.8K | 0.23% | 71 |
|
|
2021
Q4 | $457K | Buy |
6,300
+900
| +17% | +$65.3K | 0.22% | 69 |
|
|
2021
Q3 | $377K | Buy |
5,400
+100
| +2% | +$6.98K | 0.19% | 79 |
|
|
2021
Q2 | $365K | Buy |
5,300
+1,600
| +43% | +$110K | 0.19% | 81 |
|
|
2021
Q1 | $239K | Buy |
3,700
+200
| +6% | +$12.9K | 0.14% | 94 |
|
|
2020
Q4 | $204K | Buy |
+3,500
| New | +$204K | 0.13% | 93 |
|